Suchergebnisse - "Feuchtinger, Tobias"

PubPharm (187)

1

CD28-TARGETING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS, METHODS OF GENERATION AND USES THEREOF

enthalten in: Europäisches Patentamt | 2024

von FEUCHTINGER TOBIAS | WILLIER SEMJON

2

Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults

enthalten in: Haematologica | 2024

von Feuchtinger, T. | Bader, P. | Subklewe, M. | +18

3

Influence of ATLG Serum Levels on CD3/CD19-depleted Hematopoietic Grafts and on Immune Recovery in Pediatric Haplo-HSCT

enthalten in: Blood advances | 2024

von Maier, C. | Klose, C. | Seitz, C. | +18

4

Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma : Protocol of a prospective multicenter phase 2 trial

enthalten in: HNO | 2024

von Römer, T. | Vokuhl, C. | Staatz, G. | +12

5

Th1 cytokines in pediatric acute lymphoblastic leukemia

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Schober, S. | Rottenberger, J. | Hilz, J. | +6

6

Excellent outcome of stem cell transplantation for sickle cell disease

enthalten in: Annals of hematology | 2023

von Vallée, T. | Schmid, I. | Gloning, L. | +6

7

CD28-TARGETING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS, METHODS OF GENERATION AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von FEUCHTINGER TOBIAS | WILLIER SEMJON

8

CD28-TARGETING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS, METHODS OF GENERATION AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von FEUCHTINGER TOBIAS | WILLIER SEMJON

9

Excellent outcome of stem cell transplantation for sickle cell disease

enthalten in: Annals of hematology | 2023

von Vallée, T. | Schmid, I. | Gloning, L. | +6

10

Modular pooled discovery of synthetic knockin sequences to program durable cell therapies

enthalten in: Cell | 2023

von Blaeschke, F. | Chen, Y. | Apathy, R. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]